Synapse Open Synapse
Biology

STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more

STAT News · · 1 min read

India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing

Same story elsewhere

Latest from STAT News